A fucose-binding superlectin from Enterobacter cloacae with high Lewis and ABO blood group antigen specificity
Journal of Biological Chemistry · 2025
DOI: 10.1016/j.jbc.2024.108151 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Biological Chemistry, 2025. Verfasst von Ghamdan Beshr und 7 weiteren Autor:innen. Beteiligte Einrichtung: Helmholtz Institute for Pharmaceutical Research Saarland (HIPS), Helmholtz Centre for Infection Research, Saarbrücken, Germany; Deutsches Zentrum für…. Hauptthemen laut MEDLINE: Enterobacter cloacae, Lectins, Fucose, ABO Blood-Group System. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 65 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIGMS NIH HHS, European Cooperation in Science and Technology, Saarland University.
Abstract (Originalsprache)
Bacteria frequently employ carbohydrate-binding proteins, so-called lectins, to colonize and persist in a host. Thus, bacterial lectins are attractive targets for the development of new anti-infectives. To find new potential targets for anti-infectives against pathogenic bacteria, we searched for homologs of Pseudomonas aeruginosa lectins and identified homologs of LecA in Enterobacter species. Here, we recombinantly produced and biophysically characterized a homolog that comprises one LecA domain and one additional, novel protein domain. This protein was termed Enterobacter cloacae lectin A (EclA) and found to bind l-fucose. Glycan array analysis revealed a high specificity for the LewisA antigen and the type II H-antigen (blood group O) for EclA, while related antigens LewisX, Y, and B, as well as blood group A or B were not bound. We developed a competitive binding assay to quantify blood group antigen-binding specificity in solution. Finally, the crystal structure of EclA could be solved in complex with methyl α-l-selenofucoside. It revealed the unexpected binding of the carbohydrate ligand to the second domain, which comprises a novel fold that dimerizes via strand-swapping resulting in an intertwined beta sheet.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Helmholtz Institute for Pharmaceutical Research Saarland (HIPS), Helmholtz Centre for Infection Research, Saarbrücken, Germany; Deutsches Zentrum für Infektionsforschung (DZIF), Standort Hannover-Braunschweig; Departmen…
- Helmholtz Institute for Pharmaceutical Research Saarland (HIPS), Helmholtz Centre for Infection Research, Saarbrücken, Germany.
- Helmholtz Institute for Pharmaceutical Research Saarland (HIPS), Helmholtz Centre for Infection Research, Saarbrücken, Germany; Deutsches Zentrum für Infektionsforschung (DZIF), Standort Hannover-Braunschweig.
- Institut für Lebensmittelchemie, Leibniz Universität Hannover, Hannover, Germany. Electronic address: jesko.koehnke@foh.uni-hannover.de.
Förderung
- NIGMS NIH HHS
- European Cooperation in Science and Technology
- Saarland University
Zitieren
APA
Beshr, G., Sikandar, A., Gläser, J., Fares, M., Sommer, R., Wagner, S., Köhnke, J., & Titz, A. (2025). A fucose-binding superlectin from Enterobacter cloacae with high Lewis and ABO blood group antigen specificity. Journal of Biological Chemistry. https://doi.org/10.1016/j.jbc.2024.108151
Vancouver
Beshr G, Sikandar A, Gläser J, Fares M, Sommer R, Wagner S, et al. A fucose-binding superlectin from Enterobacter cloacae with high Lewis and ABO blood group antigen specificity. Journal of Biological Chemistry. 2025. doi:10.1016/j.jbc.2024.108151
BibTeX
@article{Beshr2025,
author = {Beshr, Ghamdan and Sikandar, Asfandyar and Gläser, Julia and Fares, Mario and Sommer, Roman and Wagner, Stefanie and Köhnke, Jesko and Titz, Alexander},
title = {A fucose-binding superlectin from Enterobacter cloacae with high Lewis and ABO blood group antigen specificity},
journal = {Journal of Biological Chemistry},
year = {2025},
doi = {10.1016/j.jbc.2024.108151}
}
EUVIMED